Gerência de Contas Estratégicas (Key Account Manager) - Divisão de Farmacêuticos Estabelecidos (EPD) - São Paulo/SP

Brazil

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should have experience in sales and account management within the pharmaceutical retail sector, with a strong understanding of Brazilian market dynamics, including fiscal and tax knowledge. Proven ability in negotiation, sales planning, and building customer relationships is essential. Experience with market audits (MDTR, DDD) and inventory management is also required.

Responsibilities

The Key Account Manager will be responsible for negotiating, developing, registering, and launching Abbott's products with national distributors and major retail pharmacy chains to increase market share. This includes meeting monthly sales targets, monitoring inventory levels, developing Annual Customer Business Plans (ACBP) with trade marketing, and managing promotional actions. The role also involves collaborating with various internal Abbott departments and client teams, analyzing sales data, and ensuring compliance with company policies and the Commercial Code of Conduct.

Skills

Key Account Management

Negotiation

Product Launch

Distribution Management

Retail Pharmacy

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters

1888Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.

Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.

Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.

Abbott's microfluidic devices streamline diagnostic processes efficiently.

Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.

Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.

Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI

Try Jobo Free